The global Infant Formula Milk Powder with A2 beta casein Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (0 to 6 months, 6 to 12 months, 12 to 36 months), By Application (Supermarkets/Hypermarkets, Pharmacies, Hospitals, E-commerce, Baby Store, Others)
In 2024, the market for infant formula milk powder with A2 beta casein is expanding, driven by the increasing demand for products that are easier to digest and less likely to cause allergic reactions. A2 beta casein, found naturally in certain cow's milk, is gaining popularity for its potential health benefits. The market is benefiting from growing consumer awareness and scientific research supporting the advantages of A2 protein. Innovations in breeding and milk processing technologies are enhancing the availability and quality of A2 beta casein-based infant formulas.
The market report analyses the leading companies in the industry including Abbott Nutrition (Abbott Laboratories), Beta A2 Australia Pty Ltd, Care A2+ Limited, Danone S.A., Holle baby food GmbH, Reckitt Benckiser Group plc, Nature's One, Inc., Nestlé S.A., The a2 Milk Company Limited, ZURU Inc. , and Others.
The most prominent trend in the Infant Formula Milk Powder with A2 Beta Casein Market is the increasing preference for A2 milk-based formulas. A2 milk, which contains only the A2 type of beta-casein protein, is gaining popularity due to its perceived health benefits and easier digestibility compared to regular milk that contains both A1 and A2 proteins. This trend is driven by the growing awareness of the potential digestive and health advantages of A2 milk for infants, particularly those with sensitivities to A1 protein. The demand for A2 milk-based formulas is encouraging manufacturers to develop and promote these specialized products.
A key driver for the Infant Formula Milk Powder with A2 Beta Casein Market is the growing incidence of cow milk protein sensitivity among infants. Many infants experience digestive discomfort and allergic reactions to the A1 protein found in regular cow's milk. A2 milk, which lacks the A1 protein, is considered a gentler and more suitable alternative for these infants. The rising awareness and diagnosis of cow milk protein sensitivity are significantly driving the demand for A2 milk-based infant formulas as parents seek solutions that provide the benefits of milk without the associated sensitivities.
One potential opportunity in the Infant Formula Milk Powder with A2 Beta Casein Market lies in the expansion into new geographic markets. Regions such as Asia-Pacific, where there is a high prevalence of lactose intolerance and milk protein sensitivities, present a significant opportunity for A2 milk-based formulas. By focusing on these markets and educating consumers about the benefits of A2 milk, manufacturers can tap into a large and growing consumer base. This focus on geographic expansion can drive market growth and improve access to specialized infant nutrition solutions globally.
Among the types in the Infant Formula Milk Powder with A2 beta casein Market, the 0 to 6 months type is the largest segment. This segment represents infant formula milk powder specifically formulated for newborns and infants up to 6 months old. It is designed to provide essential nutrients and support healthy growth and development during this critical early stage of life. Formulas in this segment often mimic the composition of human breast milk, incorporating A2 beta casein protein for its perceived benefits in digestion and tolerance among infants. The 0 to 6 months segment dominates the market due to the high demand for nutritionally balanced formulas that meet the unique dietary needs of newborns and young infants.
The E-commerce application segment is expected to be the fastest-growing in the Infant Formula Milk Powder with A2 beta casein Market through 2032. This growth is driven by the increasing trend of online shopping for baby products, including infant formula milk powder with specific nutritional attributes like A2 beta casein. E-commerce platforms offer parents convenience, extensive product choices, competitive pricing, and the ability to access specialized or niche products that may not be readily available in local stores. Further, the Past few yearshas accelerated the shift towards online shopping, as consumers prioritize safety and convenience. Manufacturers and retailers are investing in e-commerce infrastructure, digital marketing strategies, and logistics capabilities to capitalize on this growing segment of online shoppers seeking reliable and high-quality infant nutrition products.
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Nutrition (Abbott Laboratories)
Beta A2 Australia Pty Ltd
Care A2+ Limited
Danone S.A.
Holle baby food GmbH
Reckitt Benckiser Group plc
Nature's One, Inc.
Nestlé S.A.
The a2 Milk Company Limited
ZURU Inc.
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Infant Formula Milk Powder with A2 beta casein Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Infant Formula Milk Powder with A2 beta casein Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Infant Formula Milk Powder with A2 beta casein Market Share by Company, 2023
4.1.2. Product Offerings of Leading Infant Formula Milk Powder with A2 beta casein Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Infant Formula Milk Powder with A2 beta casein Market Drivers
6.2. Infant Formula Milk Powder with A2 beta casein Market Challenges
6.6. Infant Formula Milk Powder with A2 beta casein Market Opportunities
6.4. Infant Formula Milk Powder with A2 beta casein Market Trends
Chapter 7. Global Infant Formula Milk Powder with A2 beta casein Market Outlook Trends
7.1. Global Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Chapter 8. Global Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.1. Global Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.2.2. Canada Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.2.3. Mexico Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.3. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.3.2. France Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.3.3. United Kingdom Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.3.4. Spain Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.3.5. Italy Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.3.6. Russia Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.3.7. Rest of Europe Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.4. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Country (2021-2032)
8.4.1. China Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.4.2. Japan Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.4.3. India Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.4.4. South Korea Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.4.5. Australia Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.4.6. South East Asia Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.5. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.5.2. Argentina Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.5.3. Rest of South America Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.6. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
8.6.2. Africa Infant Formula Milk Powder with A2 beta casein Regional Analysis and Outlook
Chapter 9. North America Infant Formula Milk Powder with A2 beta casein Analysis and Outlook
9.1. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Product (2021-2032)
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Chapter 10. Europe Infant Formula Milk Powder with A2 beta casein Analysis and Outlook
10.1. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Product (2021-2032)
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Chapter 11. Asia Pacific Infant Formula Milk Powder with A2 beta casein Analysis and Outlook
11.1. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Product (2021-2032)
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Chapter 12. South America Infant Formula Milk Powder with A2 beta casein Analysis and Outlook
12.1. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Product (2021-2032)
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Chapter 13. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Analysis and Outlook
13.1. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) by Product (2021-2032)
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Chapter 14. Infant Formula Milk Powder with A2 beta casein Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Abbott Nutrition (Abbott Laboratories)
Beta A2 Australia Pty Ltd
Care A2+ Limited
Danone S.A.
Holle baby food GmbH
Reckitt Benckiser Group plc
Nature's One, Inc.
Nestlé S.A.
The a2 Milk Company Limited
ZURU Inc.
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Infant Formula Milk Powder with A2 beta casein Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Infant Formula Milk Powder with A2 beta casein Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Infant Formula Milk Powder with A2 beta casein Market Share (%) By Regions (2021-2032)
Table 12 North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Table 15 South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Region (2021-2032)
Table 17 North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Table 18 North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Table 19 North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Table 26 South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Table 27 South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Table 28 South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Infant Formula Milk Powder with A2 beta casein Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Infant Formula Milk Powder with A2 beta casein Market Share (%) By Regions (2023)
Figure 6. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 12. France Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 12. China Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 14. India Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Infant Formula Milk Powder with A2 beta casein Revenue (USD Million) By Product (2021-2032)
By Type
0 to 6 months
6 to 12 months
12 to 36 months
By Application
Supermarkets/Hypermarkets
Pharmacies
Hospitals
E-commerce
Baby Store
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Infant Formula Milk Powder with A2 beta casein Market Size is valued at $6.8 Billion in 2024 and is forecast to register a growth rate (CAGR) of 10.4% to reach $15 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Nutrition (Abbott Laboratories), Beta A2 Australia Pty Ltd, Care A2+ Limited, Danone S.A., Holle baby food GmbH, Reckitt Benckiser Group plc, Nature's One, Inc., Nestlé S.A., The a2 Milk Company Limited, ZURU Inc.
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume